Welcure Drugs and Pharmaceuticals Share Price Falls 5% as Board Approves Stock Split and Bonus Issue

Market Performance

Stock Market Today saw Welcure Drugs and Pharmaceuticals share price slipping close to 5%, hitting ₹11.33 in Monday’s trade. The decline came right after the company’s board announced key corporate actions on Friday, August 22.

Despite today’s dip, the small-cap counter has been a strong performer in recent times:

• 1 Month: Up 18%
• 6 Months: Gained nearly 67%
• 5 Years: Delivered multibagger returns of 466.5%

Such a sharp run-up shows why this stock has been on the radar of retail investors.

Main News – Key Announcements from the Board

On Friday, Welcure Drugs and Pharmaceuticals disclosed several decisions that will directly impact its capital structure:

• Stock Split: Equity shares of face value ₹10 each will be split into shares of face value ₹1 each, subject to shareholder approval through postal ballot.
• Bonus Shares: The company will issue 1 bonus share for every 10 shares held (1:10 ratio).
• Authorized Share Capital: Increased from ₹186 crore to ₹196 crore.

The company will set and announce the record date for the stock split and bonus shares after obtaining the required approvals.

Company Details

Welcure Drugs and Pharmaceuticals has been a small-cap story with big returns. Long-term investors have watched their holdings grow several times over. The company’s recent move to restructure its capital indicates an effort to improve liquidity and enhance shareholder value.

Key corporate actions announced:

• Stock Split – Each ₹10 share split into ₹1 shares
• Bonus Shares – 1 new share for every 10 shares held
• Authorized Share Capital – Raised to ₹196 crore

Summary

The sharp dip in Welcure Drugs and Pharmaceuticals share price today reflects immediate market reaction to the stock split and bonus issue news. However, the company’s consistent track record of wealth creation over the past five years shows strong investor confidence.

As of now:

• Share price: ₹11.33 (down 5%)
• Corporate actions: Stock split (1:10), Bonus issue (1:10), Capital hike to ₹196 crore
• Long-term growth: +466.5% in 5 years

For investors tracking Stock Market Today, Welcure remains a stock to watch closely as it undergoes these structural changes.